Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
1.225
-0.005 (-0.41%)
Mar 9, 2026, 2:05 PM EDT - Market open
Immunic Employees
Immunic had 91 employees as of December 31, 2024. The number of employees increased by 14 or 18.18% compared to the previous year.
Employees
91
Change (1Y)
14
Growth (1Y)
18.18%
Revenue / Employee
n/a
Profits / Employee
-$1,079,689
Market Cap
159.82M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Innate Pharma | 174 |
| Zentalis Pharmaceuticals | 166 |
| Fate Therapeutics | 161 |
| Caribou Biosciences | 147 |
| Rani Therapeutics Holdings | 106 |
| Tonix Pharmaceuticals Holding | 81 |
| Milestone Pharmaceuticals | 33 |
IMUX News
- 6 days ago - Immunic to Participate in Investor Conferences in March - PRNewsWire
- 11 days ago - Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 19 days ago - Immunic Announces Closing of Oversubscribed Private Placement Financing - PRNewsWire
- 24 days ago - Immunic Stock Jumps After Pricing $400 Million Private Placement - Benzinga
- 24 days ago - Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company - PRNewsWire
- 4 weeks ago - Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis - PRNewsWire
- 2 months ago - Immunic Highlights 2025 Accomplishments and Upcoming Milestones - PRNewsWire
- 3 months ago - Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December - PRNewsWire